BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Overview Fund Activity
Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

2 hedge funds and large institutions have $1.27M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.03%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JCI
1
Jet Capital Investors
New York
$1.27M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
JCI
1
Jet Capital Investors
New York
$1.27M 562,649 +562,649 New
BCM
2
Beddow Capital Management
Wyoming
$0 562,539 -8,590 -2%